BRCA2 and cancer: To examine whether UCP1-CRISPRa mammary adipocytes might prevent cancer development in individuals at high lifetime risk of cancer, we co-cultured them alongside breast organoids from dissected patient-matched breast tissue of BRCA1/BRCA2/RAD51D mutation carriers (Fig. 5h).